Menstrual Blood A Vital Source of Stem Cells to Treat Neurological DisordersVital menstrual blood
Research in the use of menstrual blood derived stem cells in the treatment of neurological disorders is an ongoing process at Celle, the leading company in the field of collection of menstrual blood. Clinical trials are still going on to find the optimal cell type that will benefit a large number of people afflicted with neurological disorders. Stem cells derived from preserved menstrual blood typically exhibit embryonic like stem cell phenotypic markers. When grown in the right media, these cells have suitable neuronal phenotypic markers with potential applications in neurological disorder treatments. Trials have shown that transplantation of such stem cells either intracerebrally or intravenously, without the use of immune suppression agents, in adult rats with induced stroke symptoms, resulted in reduced impairments. Abundant stem cells from menstrual blood matched the female transplant recipient in clinical trials for treatment of stroke.
Stroke causes death and disability due to secondary cellular death occurring over a long period. Celle is committed to store menstrual blood and use it as a source of stem cells in neurorestorative treatments to salvage the ischemic penumbra and help the patient recover to some extent. Cell therapy, as on date, is the only promising treatment on the horizon for management of stroke and its treatment.
Ongoing research by the company has shown that menstrual blood is regenerative and non-invasive and a rich source of stem cells from the uterine lining. These stem cells are multipotent and can be segregated into adipogenic, osteogenic, neurogenic, pulmonary epithelial, hepatic, pancreatic and cardiogenic cell lineages, with a capacity for proliferation. Stem cells from renewable menstrual blood can also be a low cost option. Studies have been conducted to focus on neural stem cells for potential use in transplants for stroke therapy, helping patients regain functionality to some extent.
In order to aid collection Celle provides complete collection and shipping kits for women, helping them collect menstrual blood on the day the discharge is the highest. Collected in a uterine cup, the blood is transferred to a bag and shipped to the company headquarters where it follows a series of procedures to separate the stem cells and store them in liquid nitrogen.
Stroke causes death and disability due to secondary cellular death occurring over a long period. Celle is committed to store menstrual blood and use it as a source of stem cells in neurorestorative treatments to salvage the ischemic penumbra and help the patient recover to some extent. Cell therapy, as on date, is the only promising treatment on the horizon for management of stroke and its treatment.
Ongoing research by the company has shown that menstrual blood is regenerative and non-invasive and a rich source of stem cells from the uterine lining. These stem cells are multipotent and can be segregated into adipogenic, osteogenic, neurogenic, pulmonary epithelial, hepatic, pancreatic and cardiogenic cell lineages, with a capacity for proliferation. Stem cells from renewable menstrual blood can also be a low cost option. Studies have been conducted to focus on neural stem cells for potential use in transplants for stroke therapy, helping patients regain functionality to some extent.
In order to aid collection Celle provides complete collection and shipping kits for women, helping them collect menstrual blood on the day the discharge is the highest. Collected in a uterine cup, the blood is transferred to a bag and shipped to the company headquarters where it follows a series of procedures to separate the stem cells and store them in liquid nitrogen.
